slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
13,52 CNY | +1,27% | +16,45% | -9,81% |
24/04 | HitGen Inc. Rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024 | CI |
23/02 | HitGen Inc. Rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 508
Verkoop per activiteit
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Deoxyribonucleic Acid Encoded Compound Library Screening Service
26,3
%
| - | - | 98 | 26,3 % | - |
Fragment-based Drug Design/Structure-based Drug Design Research & Development Services
24,5
%
| - | - | 91 | 24,5 % | - |
Deoxyribonucleic Acid Encoded Compound Library Customization Service
22,8
%
| - | - | 85 | 22,8 % | - |
Chemical Synthesis Services
14,0
%
| - | - | 52 | 14,0 % | - |
New Drug Custom Development
5,2
%
| - | - | 19 | 5,2 % | - |
Others
3,8
%
| - | - | 14 | 3,8 % | - |
Compound Structure Intellectual Property Transfer Fee
2,8
%
| - | - | 10 | 2,8 % | - |
New Drug Research Equity Transfer
0,5
%
| 17 | 5,2 % | 2 | 0,5 % | -88,90% |
Verkoop per regio
CNY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
67,3
%
| 164 | 49,8 % | 250 | 67,3 % | +52,21% |
China
16,9
%
| 69 | 20,8 % | 63 | 16,9 % | -8,40% |
Denmark
5,1
%
| 20 | 6,2 % | 19 | 5,1 % | -8,13% |
United Kingdom
3,9
%
| 11 | 3,3 % | 15 | 3,9 % | +33,50% |
Japan
2,6
%
| 5 | 1,4 % | 10 | 2,6 % | +103,57% |
South Korea
1,4
%
| 7 | 2,2 % | 5 | 1,4 % | -31,03% |
France
1,2
%
| 41 | 12,4 % | 5 | 1,2 % | -88,72% |
Other Countries
1,0
%
| 4 | 1,1 % | 4 | 1,0 % | +1,29% |
Germany
0,4
%
| 6 | 1,9 % | 1 | 0,4 % | -76,03% |
Ireland
0,2
%
| 3 | 0,8 % | 1 | 0,2 % | -70,11% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 22-02-12 |
Eliza Liu
DFI | Director of Finance/CFO | 54 | 27-04-23 |
Barry A Morgan
CTO | Chief Tech/Sci/R&D Officer | 77 | 01-06-16 |
Sui Bo Li
BRD | Director/Board Member | 63 | 01-10-18 |
Lei Zhu
IRC | Investor Relations Contact | 36 | 01-07-19 |
Shi Wei Geng
SEC | Corporate Secretary | 37 | 01-10-15 |
Guan Sai Liu
PRN | Corporate Officer/Principal | 42 | 01-09-13 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jin Li
CEO | Chief Executive Officer | 61 | 22-02-12 |
Hai Zong Yu
BRD | Director/Board Member | 60 | 24-03-19 |
Jian Guo Li
BRD | Director/Board Member | 63 | 24-03-19 |
Yong Cun Chen
BRD | Director/Board Member | 59 | 24-03-19 |
Kai Lu
BRD | Director/Board Member | 71 | 01-02-12 |
Ze Wu Liu
BRD | Director/Board Member | 71 | 24-03-19 |
Chen Hui Xu
CHM | Chairman | 58 | 01-02-12 |
Dan Liu
BRD | Director/Board Member | 41 | 27-05-22 |
Sui Bo Li
BRD | Director/Board Member | 63 | 01-10-18 |
Shao Lin Hu
BRD | Director/Board Member | 38 | 27-05-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 400 680 000 | 135 670 177 ( 33,86 %) | 1 238 700 ( 0,3091 %) | 33,86 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
HITGEN INC. 0.31% | 1 238 700 | 0.31% | 2 276 037 $ |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-9,81% | 746 mln. | |
-1,65% | 104 mld. | |
+6,75% | 97,47 mld. | |
+5,71% | 22,25 mld. | |
-12,60% | 21,68 mld. | |
-9,70% | 18,2 mld. | |
-39,98% | 17,02 mld. | |
-10,17% | 16,36 mld. | |
+6,12% | 14,39 mld. | |
+35,47% | 12,37 mld. |
- Beurs
- Aandelen
- Koers 688222
- Onderneming HitGen Inc.